Senti Biosciences, Inc. - Dinamika pendapatan YoY sajrone rolas wulan kepungkur SNTI

Logo grafis sentibio.com (SNTI)

The LTM sales growth YoY metric demonstrates the impact of early-stage clinical trials on liquidity, where the 0.00 mark records this figure. Senti Biosciences, Inc. (SNTI) minimizes risks by utilizing AI to develop gene circuits targeting liver and blood cancers. This results in a unique biotechnological environment with a protected patent portfolio, creating high value for strategic partners.

Senti Biosciences (SNTI): Wutah dodolan YoY (TTM) saka 11.02.2024 nganti 17.11.2026

Senti Biosciences (SNTI) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:
Pambiji fundamental perusahaan:Senti Bio
Barang unggulan sentibio.com

Operational business quality is determined by the ability to generate a sustainable cash flow. This indicator measures the revenue growth rate over a rolling year, neutralizing seasonality and revealing the company's actual expansion speed. This is critical for Senti Biosciences, Inc. (SNTI), as geopolitical barriers hinder the cross-border logistics of biomaterials. By analyzing the year-over-year sales dynamics over the last 12 months TTM, an investor will notice hidden inflection points in the development of gene therapy.